SMMT
Summit Therapeutics PLC
15.60$
-4.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.3% | 83.2% | 88.7% | 66.5% | 77.0% | 82.3% | 85.5% | 85.8% | 98.9% | 93.5% | 97.3% | 95.9% | |
| 58.1% | 65.0% | 74.7% | 37.3% | 44.3% | 66.2% | 64.8% | 63.3% | 52.5% | 35.2% | 24.1% | 30.0% | |
| 58.1% | 65.0% | 74.7% | 37.3% | 44.3% | 66.2% | 64.8% | 63.3% | 52.5% | 91.8% | 94.7% | 95.0% | |
| 5.2% | 6.4% | 10.1% | 17.2% | 15.7% | 0.4% | 9.9% | 15.1% | 0.9% | 0.4% | 0.1% | – | |
| 14.2% | 1.6% | 0.2% | 0.0% | 0.0% | 0.0% | -15.6% | 8.5% | 1.3% | 1.5% | – | – | |
| 0.3% | 0.2% | 0.2% | 1.1% | 0.8% | 1.5% | 1.7% | 4.1% | 0.9% | – | – | – | |
| 3.4% | 2.6% | 1.8% | 4.6% | 3.0% | 1.5% | 2.0% | 1.8% | 0.3% | 0.9% | 0.4% | 0.3% | |
| 18.0% | 13.8% | 9.2% | 27.4% | 17.5% | 10.2% | 11.2% | 9.2% | 1.9% | – | – | – | |
| 33.2% | 15.7% | 109.3% | 81.7% | 29.8% | 19.0% | 22.5% | 26.5% | 80.9% | 61.7% | 10.7% | 12.3% | |
| 18.4% | 12.8% | 29.0% | 35.1% | 21.6% | 13.1% | 19.4% | 22.6% | 5.8% | 10.1% | 9.6% | 9.7% | |
| – | 14.3% | 10.8% | 23.6% | 0.0% | -0.9% | 0.4% | 1.0% | 3.2% | 1.4% | 0.9% | 0.5% | |
| 18.4% | 12.8% | 10.6% | 16.6% | 7.3% | 4.5% | 6.0% | 3.9% | 0.1% | 1.3% | 1.1% | 2.7% | |
| – | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 91.3% | 62.3% | – | – | |
| 66.8% | 84.3% | -9.3% | 18.3% | 70.2% | 81.0% | 77.5% | 73.5% | 19.1% | 38.3% | 89.3% | 87.7% | |
| -166.3% | -188.8% | -196.3% | -149.9% | -125.5% | -158.3% | -205.8% | -264.2% | -57.0% | -489.4% | -278.9% | -305.4% | |
| 135.5% | 165.5% | 131.0% | 85.7% | 108.3% | 43.5% | 92.3% | 109.8% | 35.7% | 385.8% | 206.4% | 134.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.